Chronic kidney disease: open trials in Chile

• NCT06742723

  A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  Trial Treatment · Phase 3 · AstraZeneca

  Araucania · Santiago · Talcahuano · Valdivia · Victoria · Viña del Mar

  Registry updated 2026-11-06

• NCT06823115

  Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0

  Research · Indiana University

  Hospital Guillermo Grant Benavente, Concepción · Hospital Clinico Universidad Catolica de Chile, Santiago

  Registry updated 2026-10-28

• NCT04557462

  A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Temuco

  Registry updated 2026-10-05

• NCT03549754

  iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases

  Research · AstraZeneca

  Providencia

  Registry updated 2026-09-09

• NCT07753993

  A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  Trial Treatment · Phase 3 · AstraZeneca

  Araucania · Osorno · Region Metropolitana · Santiago · Temuco · Victoria · Viña del Mar

  Registry updated 2026-09-09

• NCT07776925

  Effects of Maqui Supplementation on Gut Microbiota, Inflammation, and Oxidative Stress in Patients With Chronic Kidney Disease

  Trial Treatment · Universidad Mayor

  Santiago, Santiago

  Registry updated 2026-08-20

All Chronic kidney disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error